Vinblastine differs from Taxol as it inhibits the malignant phenotypes of NSCLC cells by increasing the phosphorylation of Op18/stathmin
Fang Shen(Changsha Medical University), Xuechi Lin(Changsha Medical University)
Cited by 35
Related Papers
The Cdc2/Cdk1 inhibitor, purvalanol A, enhances the cytotoxic effects of taxol through Op18/stathmin in non-small cell lung cancer cells in vitro
|International Journal of Molecular Medicine|2017|95